Nifty
:
24246.70
Sensex
:
79801.43
-82.25 (-0.34%)
-315.06 (-0.39%)
Nifty
Sensex
:
:
24246.70
79801.43
-82.25 (-0.34%)
-315.06 (-0.39%)

Dishman Carbogen Amcis Ltd.

Pharmaceuticals & Drugs - Global

Rating :
N/A

BSE: 540701 | NSE: DCAL

NSE BSE
246.93
06-Feb-2025
  • Open
  • High
  • Low
  • Previous Close
  •  244.75
  •  251.00
  •  244.45
  •  244.38
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  255550
  •  631.81
  •  307.98
  •  133.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 3,275.20
  • N/A
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 5,048.57
  • N/A
  • 0.57

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 59.32%
  • 2.04%
  • 25.31%
  • FII
  • DII
  • Others
  • 9.49%
  • 1.06%
  • 2.78%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 5.06
  • 6.91

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -11.91
  • -4.12

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 65.36
  • -
  • 35.86

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 7.03
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 3.08
  • 0.93
  • 1.25

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 10.08
  • 10.79
  • 12.21

Earnings Forecasts:

Description
2024
2025
2026
2027
Adj EPS
-4.87
P/E Ratio
Revenue
327
EBITDA
16
Net Income
-76
ROA
-1.5
P/B Ratio
0.89
ROE
-1.87
FCFF
-5.78
FCFF Yield
-0.1

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Net Sales
682.34
651.09
4.80%
789.04
586.59
34.51%
523.78
723.38
-27.59%
654.71
618.56
5.84%
Expenses
542.21
609.98
-11.11%
641.89
525.74
22.09%
494.81
601.52
-17.74%
592.03
567.12
4.39%
EBITDA
140.13
41.11
240.87%
147.15
60.85
141.82%
28.97
121.86
-76.23%
62.68
51.44
21.85%
EBIDTM
20.54%
6.31%
18.65%
10.37%
5.53%
16.85%
9.57%
8.32%
Other Income
5.63
6.05
-6.94%
6.65
8.47
-21.49%
1.43
6.53
-78.10%
7.16
6.75
6.07%
Interest
48.78
33.08
47.46%
36.63
27.49
33.25%
31.93
28.45
12.23%
30.95
24.43
26.69%
Depreciation
71.97
80.37
-10.45%
72.09
75.04
-3.93%
70.59
70.45
0.20%
85.00
75.74
12.23%
PBT
27.05
-66.29
-
42.12
-36.26
-
-77.56
29.49
-
-49.20
-87.60
-
Tax
22.42
-6.66
-
9.03
4.64
94.61%
0.01
12.49
-99.92%
20.72
-16.88
-
PAT
4.63
-59.63
-
33.09
-40.90
-
-77.57
17.00
-
-69.92
-70.72
-
PATM
0.68%
-9.16%
4.19%
-6.97%
-14.81%
2.35%
-10.68%
-11.43%
EPS
0.30
-3.80
-
2.11
-2.61
-
-4.95
1.08
-
-4.46
-4.51
-

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Net Sales
2,649.87
2,615.77
2,412.92
2,140.69
1,912.03
2,043.60
2,058.60
1,694.79
1,713.69
Net Sales Growth
2.72%
8.41%
12.72%
11.96%
-6.44%
-0.73%
21.47%
-1.10%
 
Cost Of Goods Sold
537.15
597.19
516.82
447.42
468.15
458.72
403.78
336.93
329.30
Gross Profit
2,112.72
2,018.58
1,896.10
1,693.27
1,443.88
1,584.88
1,654.82
1,357.86
1,384.39
GP Margin
79.73%
77.17%
78.58%
79.10%
75.52%
77.55%
80.39%
80.12%
80.78%
Total Expenditure
2,270.94
2,351.85
2,080.72
1,815.04
1,637.82
1,546.04
1,506.70
1,256.77
1,260.34
Power & Fuel Cost
-
104.29
87.57
62.58
41.28
60.26
56.79
48.67
49.74
% Of Sales
-
3.99%
3.63%
2.92%
2.16%
2.95%
2.76%
2.87%
2.90%
Employee Cost
-
1,208.16
1,029.86
981.49
872.91
762.27
714.64
625.40
596.02
% Of Sales
-
46.19%
42.68%
45.85%
45.65%
37.30%
34.71%
36.90%
34.78%
Manufacturing Exp.
-
209.66
171.92
144.91
118.31
118.03
114.69
83.69
98.02
% Of Sales
-
8.02%
7.12%
6.77%
6.19%
5.78%
5.57%
4.94%
5.72%
General & Admin Exp.
-
159.33
142.69
104.71
82.76
90.42
157.80
112.15
81.58
% Of Sales
-
6.09%
5.91%
4.89%
4.33%
4.42%
7.67%
6.62%
4.76%
Selling & Distn. Exp.
-
24.80
35.47
29.44
21.94
23.40
20.90
18.56
58.54
% Of Sales
-
0.95%
1.47%
1.38%
1.15%
1.15%
1.02%
1.10%
3.42%
Miscellaneous Exp.
-
48.42
96.39
44.49
32.47
32.94
38.10
31.37
47.14
% Of Sales
-
1.85%
3.99%
2.08%
1.70%
1.61%
1.85%
1.85%
2.75%
EBITDA
378.93
263.92
332.20
325.65
274.21
497.56
551.90
438.02
453.35
EBITDA Margin
14.30%
10.09%
13.77%
15.21%
14.34%
24.35%
26.81%
25.85%
26.45%
Other Income
20.87
50.79
27.77
49.14
38.59
44.46
53.82
53.02
26.13
Interest
148.29
119.97
85.69
56.81
47.61
61.95
56.55
48.83
49.01
Depreciation
299.65
310.86
280.72
307.59
307.94
282.87
240.38
211.42
213.50
PBT
-57.59
-116.12
-6.44
10.39
-42.75
197.20
308.79
230.79
216.97
Tax
52.18
31.19
-24.79
-22.26
100.10
38.69
98.46
76.22
70.65
Tax Rate
-90.61%
-25.51%
45.41%
523.76%
-153.93%
19.62%
31.89%
33.03%
32.56%
PAT
-109.77
-153.45
-29.80
18.01
-165.13
158.51
210.33
154.57
146.32
PAT before Minority Interest
-109.77
-153.45
-29.80
18.01
-165.13
158.51
210.33
154.57
146.32
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
-4.14%
-5.87%
-1.24%
0.84%
-8.64%
7.76%
10.22%
9.12%
8.54%
PAT Growth
0.00%
-
-
-
-
-24.64%
36.07%
5.64%
 
EPS
-7.00
-9.79
-1.90
1.15
-10.53
10.11
13.41
9.86
9.33

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Shareholder's Funds
5,627.50
5,809.67
5,548.94
5,698.82
5,715.06
5,379.09
5,107.33
4,813.98
Share Capital
31.36
31.36
31.36
31.36
31.38
32.28
32.28
0.00
Total Reserves
5,596.14
5,778.31
5,517.58
5,667.46
5,683.68
5,346.81
5,075.05
3.98
Non-Current Liabilities
1,388.40
1,831.43
1,665.47
1,366.74
909.40
743.13
883.95
766.66
Secured Loans
245.61
1,046.65
761.96
503.94
222.41
310.55
386.16
241.45
Unsecured Loans
0.00
0.00
0.00
0.00
18.89
51.87
138.81
218.67
Long Term Provisions
379.04
233.16
277.09
310.99
294.08
248.31
234.34
221.40
Current Liabilities
2,554.72
1,798.39
1,419.79
1,290.30
1,568.95
1,198.31
1,177.72
993.66
Trade Payables
244.12
219.73
193.37
169.23
283.52
194.57
185.92
85.64
Other Current Liabilities
639.53
841.64
702.41
558.68
578.83
430.36
515.88
457.19
Short Term Borrowings
1,620.23
680.76
492.64
542.47
688.23
520.09
393.31
384.95
Short Term Provisions
50.84
56.26
31.37
19.92
18.37
53.29
82.61
65.88
Total Liabilities
9,570.62
9,439.49
8,634.20
8,355.86
8,193.41
7,320.53
7,169.00
6,574.30
Net Block
6,720.08
6,183.17
5,768.14
5,693.34
5,672.85
5,092.37
5,060.70
4,847.25
Gross Block
10,308.49
9,457.72
8,633.43
8,155.29
7,890.70
6,896.88
6,621.19
6,187.07
Accumulated Depreciation
3,588.41
3,274.55
2,865.29
2,461.95
2,217.85
1,804.51
1,560.49
1,339.82
Non Current Assets
7,642.43
7,521.13
6,795.48
6,651.72
6,414.44
5,766.95
5,622.85
5,241.25
Capital Work in Progress
645.74
1,043.25
779.51
485.78
234.17
175.25
150.71
132.88
Non Current Investment
78.85
72.10
31.83
55.78
89.09
152.61
106.60
44.25
Long Term Loans & Adv.
192.78
217.24
210.78
411.53
412.88
345.40
299.33
200.63
Other Non Current Assets
0.66
0.81
0.66
0.35
5.45
1.32
5.51
16.24
Current Assets
1,928.19
1,918.36
1,838.72
1,704.14
1,778.97
1,553.58
1,546.15
1,333.05
Current Investments
23.29
176.97
292.53
116.44
106.61
19.72
94.35
0.00
Inventories
882.89
803.80
645.12
515.65
580.87
548.62
484.56
426.58
Sundry Debtors
461.11
589.91
473.42
420.71
577.43
445.30
444.40
285.55
Cash & Bank
413.35
189.17
172.09
307.74
160.98
95.67
69.06
87.39
Other Current Assets
147.55
37.54
66.08
146.03
353.08
444.27
453.78
533.53
Short Term Loans & Adv.
79.04
120.97
189.48
197.57
277.10
309.17
373.27
361.20
Net Current Assets
-626.53
119.97
418.93
413.84
210.02
355.27
368.43
339.39
Total Assets
9,570.62
9,439.49
8,634.20
8,355.86
8,193.41
7,320.53
7,169.00
6,574.30

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Cash From Operating Activity
383.97
265.95
354.85
512.66
585.14
282.03
226.44
302.65
PBT
-122.26
-54.59
-4.25
-65.03
197.20
308.79
230.79
216.08
Adjustment
381.37
392.46
325.36
312.54
330.11
277.24
235.49
231.80
Changes in Working Capital
143.83
-37.73
90.08
316.35
132.23
-174.47
-206.26
-29.43
Cash after chg. in Working capital
402.94
300.14
411.19
563.86
659.54
411.56
260.02
418.45
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-18.97
-34.19
-56.34
-51.20
-74.40
-129.53
-33.58
-115.80
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-229.52
-494.08
-618.53
-380.02
-441.74
-169.02
-297.16
-142.41
Net Fixed Assets
-47.06
-143.00
28.96
-52.16
-76.56
-15.68
-66.76
Net Investments
64.69
119.43
-150.57
18.40
6.58
30.41
-175.91
Others
-247.15
-470.51
-496.92
-346.26
-371.76
-183.75
-54.49
Cash from Financing Activity
-22.15
249.68
130.37
-11.04
-97.78
-102.20
77.63
-137.08
Net Cash Inflow / Outflow
132.30
21.55
-133.31
121.60
45.62
10.81
6.91
23.16
Opening Cash & Equivalents
131.79
110.24
243.55
121.94
76.32
65.52
58.61
0.00
Closing Cash & Equivalent
264.09
131.79
110.24
243.54
121.94
76.33
65.52
58.61

Financial Ratios

Standalone /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Book Value (Rs.)
358.90
370.51
353.89
363.45
364.25
333.28
316.44
0.00
ROA
-1.61%
-0.33%
0.21%
-2.00%
2.04%
2.90%
2.25%
2.23%
ROE
-2.68%
-0.52%
0.32%
-2.89%
2.86%
4.01%
6.05%
3676.38%
ROCE
-0.03%
0.43%
0.76%
-0.26%
3.93%
5.79%
4.67%
4.61%
Fixed Asset Turnover
0.26
0.27
0.26
0.24
0.28
0.30
0.26
0.28
Receivable days
73.33
80.42
76.23
95.27
91.33
78.87
78.60
60.82
Inventory Days
117.68
109.59
98.96
104.66
100.87
91.59
98.11
90.86
Payable days
141.75
145.87
147.90
176.50
49.83
43.67
37.47
22.81
Cash Conversion Cycle
49.26
44.14
27.28
23.44
142.37
126.80
139.24
128.86
Total Debt/Equity
0.35
0.31
0.26
0.20
0.18
0.19
0.21
238.62
Interest Cover
-0.02
0.36
0.93
-0.37
4.18
6.46
5.73
5.43

Annual Reports:

FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016

News Update:


  • Dishman Carbogen Amcis’ arm gets drug manufacturing license from NMPA for Shanghai facility
    22nd Apr 2025, 11:52 AM

    This milestone marks a pivotal step in Carbogen Amcis’ expansion in China and reinforces its commitment to customers in the region

    Read More
  • Dishman Carbogen Amcis raises Rs 50 crore through NCDs
    26th Mar 2025, 15:51 PM

    The Management Committee of Board of Directors has at its meeting held on March 26, 2025 approved allotment of the same

    Read More
  • Dishman Carbogen Amcis’ arm receives Certificate of GMP Compliance form ANSM
    20th Mar 2025, 13:00 PM

    CARBOGEN AMCIS SAS has received the certificate for its Saint-Beauzire Site in France

    Read More
  • Dishman Carbogen Amc - Quarterly Results
    12th Feb 2025, 20:05 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.